|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Oyster Point Pharma, Inc. (OYST) |
|
|
$11.17 0.00 (0.00%) as of 4:30 Fri 12/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
21,360,000 |
| Market
Cap: |
238.59(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$11.17 - $11.17 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oyster Point Pharma is a biopharmaceutical company focused on the discovery, development and commercialization of pharmaceutical therapies to treat ophthalmic diseases. Co.'s development pipeline includes: Small Molecule Programs, which consist of Tyrvaya™ (varenicline solution) Nasal Spray for the indication of dry eye disease, and OC-01 (varenicline solution) nasal spray for the indication of Neurotrophic Keratopathy Stage 1; and ETF™ Gene Therapy Approach, which consists of OC-101 adeno-associated virus (AAV)-Nerve Growth Factor for the indication of Neurotrophic Keratopathy Stage 2 and 3, and OC-103 AAV for the indication of Vernal Keratoconjunctivitis/Severe Allergic Conjunctivitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
I/I |
82,491 |
82,491 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-03-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(404,849) |
10,448 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
193 |
7,165 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
I/I |
82,491 |
82,491 |
|
- |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2021-02-24 |
4 |
OE |
$11.51 |
$104,845 |
D/D |
9,109 |
34,631 |
|
- |
|
| Nau Jeffrey |
President and CEO |
• • – |
2021-02-19 |
4 |
OE |
$1.02 |
$10,200 |
D/D |
10,000 |
40,898 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
372 |
6,972 |
|
- |
|
| Clare Ozawa |
Director |
– • • |
2021-02-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(337,107) |
0 |
|
-31% |
|
| Clare Ozawa |
Director |
– • • |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
12,107 |
5,607 |
|
- |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-02-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(12,107) |
0 |
|
-31% |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
12,107 |
5,607 |
|
- |
|
| Versant Side Fund Iv, L.p. |
10% Owner |
– – • |
2021-02-17 |
4 |
AS |
$0.00 |
$0 |
D/D |
(325,000) |
2,236,888 |
|
-31% |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,222 |
25,522 |
|
- |
|
| Nau Jeffrey |
President and CEO |
• • – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
25,898 |
30,898 |
|
- |
|
| Snisarenko John |
Chief Commercial Officer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,222 |
18,222 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
I/I |
27,942 |
27,942 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2020-12-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(955,392) |
0 |
|
- |
|
| Atieh Michael G |
Director |
– • – |
2020-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
19,695 |
19,695 |
|
- |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2020-09-25 |
4 |
OE |
$11.51 |
$46,040 |
D/D |
4,000 |
14,300 |
|
- |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2020-08-11 |
4/A |
OE |
$11.51 |
$46,040 |
D/D |
4,000 |
10,300 |
|
- |
|
| Lochner Daniel |
Chief Financial Officer |
• – – |
2020-08-11 |
4 |
OE |
$11.51 |
$46,040 |
D/D |
4,000 |
4,000 |
|
- |
|
| Snisarenko John |
Chief Commercial Officer |
• – – |
2020-08-10 |
4 |
B |
$25.97 |
$103,880 |
D/D |
4,000 |
7,000 |
2.74 |
-23% |
|
| Nau Jeffrey |
President and CEO |
• • – |
2020-07-28 |
4 |
OE |
$1.02 |
$5,100 |
D/D |
5,000 |
5,000 |
|
- |
|
| Link William J Phd |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
6,600 |
|
- |
|
| Murray Mark Anthony |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
115,047 |
|
- |
|
140 Records found
|
|
Page 4 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
